AYTU BIOPHARMA, INC Financing Cash Flow
AYTU BIOPHARMA, INC (AYTU) reported Financing Cash Flow of -$7.90 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-09-22
- AYTU BIOPHARMA, INC net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$4.80M, a 136.95% decline year-over-year.
- AYTU BIOPHARMA, INC net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $872.00K, a 79.72% decline year-over-year.
- AYTU BIOPHARMA, INC net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$6.26M.
- AYTU BIOPHARMA, INC net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $2.30M, a 152.03% increase year-over-year.
- AYTU BIOPHARMA, INC net cash provided by (used in) financing activities for fiscal 2026 was -$7.90M, a 151.13% decline from fiscal 2025.
- AYTU BIOPHARMA, INC net cash provided by (used in) financing activities for fiscal 2025 was $15.44M.
- AYTU BIOPHARMA, INC net cash provided by (used in) financing activities for fiscal 2024 was -$1.26M, a 114.23% decline from fiscal 2023.
- AYTU BIOPHARMA, INC net cash provided by (used in) financing activities for fiscal 2023 was $8.87M, a 479.80% increase from fiscal 2022.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed | Net Cash Provided by (Used in) Financing Activities 81 month | Net Cash Provided by (Used in) Financing Activities 84 month | Net Cash Provided by (Used in) Financing Activities 87 month | Net Cash Provided by (Used in) Financing Activities 90 month | Net Cash Provided by (Used in) Financing Activities 93 month | Net Cash Provided by (Used in) Financing Activities 96 month | Net Cash Provided by (Used in) Financing Activities 99 month | Net Cash Provided by (Used in) Financing Activities 102 month | Net Cash Provided by (Used in) Financing Activities 105 month | Net Cash Provided by (Used in) Financing Activities 108 month | Net Cash Provided by (Used in) Financing Activities 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | -$3.93M derived: sum of 2 quarters · filed 2026-09-22 | -$10.19M derived: sum of 3 quarters · filed 2026-09-22 | -$7.90M 10-K · filed 2026-09-22 | |||||||||||||||
| 2026-03-31 | $872.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$5.39M derived: sum of 2 quarters · filed 2026-05-13 | -$3.10M 10-Q · filed 2026-05-13 | $9.90M derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||||||
| 2025-12-31 | -$6.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | -$3.97M 10-Q · filed 2026-02-03 | $9.03M derived: sum of 3 quarters · filed 2026-09-22 | $13.32M derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||||||
| 2025-09-30 | $2.30M 10-Q · filed 2025-11-13 | $15.29M derived: sum of 2 quarters · filed 2026-09-22 | $19.59M derived: sum of 3 quarters · filed 2026-09-22 | $16.83M derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||||||
| 2025-06-30 | $12.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $17.29M derived: sum of 2 quarters · filed 2026-09-22 | $14.53M derived: sum of 3 quarters · filed 2026-09-22 | $15.44M 10-K · filed 2026-09-22 | |||||||||||||||
| 2025-03-31 | $4.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $1.54M derived: sum of 2 quarters · filed 2026-05-13 | $2.45M 10-Q · filed 2026-05-13 | $3.52M derived: sum of 4 quarters · filed 2026-05-13 | |||||||||||||||
| 2024-12-31 | -$2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | -$1.85M 10-Q · filed 2026-02-03 | -$781.00K derived: sum of 3 quarters · filed 2026-02-03 | -$251.00K derived: sum of 4 quarters · filed 2026-02-03 | |||||||||||||||
| 2024-09-30 | $911.00K 10-Q · filed 2025-11-13 | $1.98M derived: sum of 2 quarters · filed 2025-11-13 | $911.00K 10-Q · filed 2024-11-13 | $2.38M derived: sum of 4 quarters · filed 2025-11-13 | |||||||||||||||
| 2024-06-30 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $1.60M derived: sum of 2 quarters · filed 2025-09-23 | $1.47M derived: sum of 3 quarters · filed 2025-09-23 | -$1.26M 10-K · filed 2025-09-23 | |||||||||||||||
| 2024-03-31 | $530.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $404.00K derived: sum of 2 quarters · filed 2025-05-14 | -$2.33M 10-Q · filed 2025-05-14 | -$7.73M derived: sum of 4 quarters · filed 2025-05-14 | |||||||||||||||
| 2023-12-31 | -$126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | -$2.86M 10-Q · filed 2025-02-12 | -$8.26M derived: sum of 3 quarters · filed 2025-02-12 | -$5.68M derived: sum of 4 quarters · filed 2025-02-12 | |||||||||||||||
| 2023-09-30 | -$2.73M 10-Q · filed 2023-11-14 | -$8.14M derived: sum of 2 quarters · filed 2024-09-26 | -$2.73M 10-Q · filed 2024-11-13 | -$7.42M derived: sum of 4 quarters · filed 2024-09-26 | |||||||||||||||
| 2023-06-30 | -$5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | -$2.82M derived: sum of 2 quarters · filed 2024-09-26 | -$4.69M derived: sum of 3 quarters · filed 2024-09-26 | $8.87M 10-K · filed 2024-09-26 | |||||||||||||||
| 2023-03-31 | $2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $718.00K derived: sum of 2 quarters · filed 2024-05-15 | $14.28M 10-Q · filed 2024-05-15 | $13.16M derived: sum of 4 quarters · filed 2024-05-15 | |||||||||||||||
| 2022-12-31 | -$1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $11.69M 10-Q · filed 2024-02-14 | $10.57M derived: sum of 3 quarters · filed 2024-02-14 | $12.10M derived: sum of 4 quarters · filed 2024-02-14 | |||||||||||||||
| 2022-09-30 | $13.56M 10-Q · filed 2023-11-14 | $12.44M derived: sum of 2 quarters · filed 2023-11-14 | $13.96M derived: sum of 3 quarters · filed 2023-11-14 | $20.55M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||||||
| 2022-06-30 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | $404.00K derived: sum of 2 quarters · filed 2023-10-12 | $6.99M derived: sum of 3 quarters · filed 2023-10-12 | $1.53M 10-K · filed 2023-10-12 | |||||||||||||||
| 2022-03-31 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | $8.11M derived: sum of 2 quarters · filed 2023-05-11 | $2.65M 10-Q · filed 2023-05-11 | $14.46M derived: sum of 4 quarters · filed 2023-05-11 | |||||||||||||||
| 2021-12-31 | $6.59M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-02-21 | $1.13M 10-Q · filed 2023-02-21 | $12.94M derived: sum of 3 quarters · filed 2023-02-21 | $6.54M derived: sum of 4 quarters · filed 2023-02-21 | |||||||||||||||
| 2021-09-30 | -$5.46M 10-Q/A · filed 2023-02-21 | $6.35M derived: sum of 2 quarters · filed 2023-02-21 | -$48.00K derived: sum of 3 quarters · filed 2023-02-21 | $27.03M derived: sum of 4 quarters · filed 2023-02-21 | |||||||||||||||
| 2021-06-30 | $11.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $5.42M derived: sum of 2 quarters · filed 2022-09-27 | $32.49M derived: sum of 3 quarters · filed 2022-09-27 | $30.31M 10-K · filed 2022-09-27 | |||||||||||||||
| 2021-03-31 | -$6.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $20.68M derived: sum of 2 quarters · filed 2022-05-16 | $18.50M 10-Q · filed 2022-05-16 | $18.50M 10-Q · filed 2021-05-17 | $12.13M derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||||||
| 2020-12-31 | $27.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $24.90M 10-Q · filed 2022-02-14 | $24.90M 10-Q · filed 2021-02-11 | $18.53M derived: sum of 3 quarters · filed 2022-02-14 | $86.71M derived: sum of 4 quarters · filed 2022-02-14 | ||||||||||||||
| 2020-09-30 | -$2.18M 10-Q · filed 2021-11-15 | -$2.18M 10-Q · filed 2020-11-12 | -$8.55M derived: sum of 2 quarters · filed 2021-11-15 | $59.63M derived: sum of 3 quarters · filed 2021-11-15 | $68.89M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||||||
| 2020-06-30 | -$6.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $61.81M derived: sum of 2 quarters · filed 2021-09-28 | $71.07M derived: sum of 3 quarters · filed 2021-09-28 | $71.07M 10-K · filed 2021-09-28 | $71.07M 10-K · filed 2020-10-06 | ||||||||||||||
| 2020-03-31 | $68.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | $77.44M derived: sum of 2 quarters · filed 2021-05-17 | $77.44M 10-Q · filed 2021-05-17 | $77.56M derived: sum of 4 quarters · filed 2021-05-17 | |||||||||||||||
| 2019-12-31 | $9.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-11 | $9.26M 10-Q · filed 2021-02-11 | $9.37M derived: sum of 3 quarters · filed 2021-02-11 | $9.63M derived: sum of 4 quarters · filed 2021-02-11 | |||||||||||||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 | $116.51K derived: sum of 2 quarters · filed 2020-11-12 | $375.02K derived: sum of 3 quarters · filed 2020-11-12 | $19.08M derived: sum of 4 quarters · filed 2020-11-12 | |||||||||||||||
| 2019-06-30 | $116.51K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | $375.02K derived: sum of 2 quarters · filed 2020-10-06 | $19.08M derived: sum of 3 quarters · filed 2020-10-06 | $19.08M 10-K · filed 2020-10-06 | |||||||||||||||
| 2019-03-31 | $258.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | $18.96M derived: sum of 2 quarters · filed 2020-05-15 | $18.96M 10-Q · filed 2020-05-15 | $18.93M derived: sum of 4 quarters · filed 2020-05-15 | |||||||||||||||
| 2018-12-31 | $18.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $18.70M 10-Q · filed 2020-02-14 | $18.68M derived: sum of 3 quarters · filed 2020-02-14 | $30.92M derived: sum of 4 quarters · filed 2020-02-14 | |||||||||||||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-14 | -$23.73K derived: sum of 2 quarters · filed 2019-11-14 | $12.22M derived: sum of 3 quarters · filed 2019-11-14 | $12.22M derived: sum of 4 quarters · filed 2019-11-14 | |||||||||||||||
| 2018-06-30 | -$23.73K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | $12.22M derived: sum of 2 quarters · filed 2019-09-26 | $12.22M derived: sum of 3 quarters · filed 2019-09-26 | $22.66M 10-K · filed 2019-09-26 | |||||||||||||||
| 2018-03-31 | $12.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | $12.25M derived: sum of 2 quarters · filed 2019-05-14 | $22.68M 10-Q · filed 2019-05-14 | ||||||||||||||||
| 2017-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-14 | $10.44M 10-Q · filed 2019-05-14 | |||||||||||||||||
| 2017-09-30 | $10.44M 10-Q · filed 2018-11-07 | ||||||||||||||||||
| 2017-06-30 | $10.19M 10-K · filed 2018-09-06 | ||||||||||||||||||
| 2015-02-28 | $4.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-15 | $20.51K 10-Q · filed 2015-04-15 | |||||||||||||||||
| 2014-11-30 | $16.01K 10-Q · filed 2015-01-12 | ||||||||||||||||||
| 2014-05-31 | $23.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-10 | $31.27K derived: sum of 2 quarters · filed 2015-04-15 | $36.72K 10-Q · filed 2014-07-10 | $43.08K derived: sum of 4 quarters · filed 2015-04-15 | $388.84K 10-Q · filed 2014-07-10 | ||||||||||||||
| 2014-02-28 | $8.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-15 | $13.52K 10-Q · filed 2015-04-15 | $19.88K derived: sum of 3 quarters · filed 2015-04-15 | $32.70K derived: sum of 4 quarters · filed 2015-04-15 | $365.64K 10-Q · filed 2014-04-11 | ||||||||||||||
| 2013-11-30 | $5.44K 10-Q · filed 2015-01-12 | $11.81K derived: sum of 2 quarters · filed 2015-01-12 | $24.62K derived: sum of 3 quarters · filed 2015-01-12 | $35.39K derived: sum of 4 quarters · filed 2015-01-12 | $357.56K 10-Q · filed 2014-01-10 | ||||||||||||||
| 2013-08-31 | $6.37K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | $19.18K derived: sum of 2 quarters · filed 2014-11-26 | $29.95K derived: sum of 3 quarters · filed 2014-11-26 | $39.46K 10-K · filed 2014-11-26 | $352.12K 10-K · filed 2014-11-26 | ||||||||||||||
| 2013-05-31 | $12.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-10 | $23.58K derived: sum of 2 quarters · filed 2014-07-10 | $33.09K 10-Q · filed 2014-07-10 | $45.71K derived: sum of 4 quarters · filed 2014-11-26 | $345.75K 10-Q · filed 2013-06-28 | ||||||||||||||
| 2013-02-28 | $10.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-11 | $20.27K 10-Q · filed 2014-04-11 | $32.90K derived: sum of 3 quarters · filed 2014-11-26 | $38.00K derived: sum of 4 quarters · filed 2014-11-26 | $332.94K 10-Q · filed 2013-04-15 | ||||||||||||||
| 2012-11-30 | $9.51K 10-Q · filed 2014-01-10 | $22.13K derived: sum of 2 quarters · filed 2014-11-26 | $27.24K derived: sum of 3 quarters · filed 2014-11-26 | $34.74K derived: sum of 4 quarters · filed 2014-11-26 | $322.17K 10-Q · filed 2013-01-14 | ||||||||||||||
| 2012-08-31 | $12.63K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | $17.73K derived: sum of 2 quarters · filed 2014-11-26 | $25.23K derived: sum of 3 quarters · filed 2014-11-26 | $33.97K 10-K · filed 2014-11-26 | $312.67K 10-K · filed 2012-11-29 | ||||||||||||||
| 2012-05-31 | $5.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-06-28 | $12.61K derived: sum of 2 quarters · filed 2013-06-28 | $21.34K 10-Q · filed 2013-06-28 | $27.62K derived: sum of 4 quarters · filed 2013-06-28 | $300.04K 10-Q · filed 2012-06-26 | ||||||||||||||
| 2012-02-29 | $7.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-04-15 | $16.23K 10-Q · filed 2013-04-15 | $22.52K derived: sum of 3 quarters · filed 2013-04-15 | $40.76K derived: sum of 4 quarters · filed 2013-04-15 | $294.94K 10-Q · filed 2012-04-12 | ||||||||||||||
| 2011-11-30 | $8.73K 10-Q · filed 2013-01-14 | $15.02K derived: sum of 2 quarters · filed 2013-01-14 | $33.26K derived: sum of 3 quarters · filed 2013-01-14 | $64.75K derived: sum of 4 quarters · filed 2013-01-14 | $287.44K 10-Q · filed 2011-12-23 | ||||||||||||||
| 2011-08-31 | $6.28K derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-29 | $24.52K derived: sum of 2 quarters · filed 2012-11-29 | $56.02K derived: sum of 3 quarters · filed 2012-11-29 | $67.27K 10-K · filed 2012-11-29 | |||||||||||||||
| 2011-05-31 | $18.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-06-26 | $49.74K derived: sum of 2 quarters · filed 2012-06-26 | $60.99K 10-Q · filed 2012-06-26 | ||||||||||||||||
| 2011-02-28 | $31.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-04-12 | $42.74K 10-Q · filed 2012-04-12 | |||||||||||||||||
| 2010-11-30 | $11.25K 10-Q · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |